{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:49:01Z","timestamp":1765828141366,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.medcli.2021.07.029","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T20:29:59Z","timestamp":1640204999000},"page":"152.e1-152.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recomendaciones de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y el tratamiento de la hipofosfatemia ligada al cromosoma X: un consenso basado en el m\u00e9todo ADAPTE"],"prefix":"10.1016","volume":"159","author":[{"given":"Domingo","family":"Gonz\u00e1lez-Lamu\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Lorente Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Luis Yanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Mar\u00edn-del Barrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Mart\u00ednez D\u00edaz-Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Peris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Ruppe MD. X-Linked Hypophosphatemia. 2012 Feb 9 [acualizado 13 Abr 2017]. En: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021.","key":"10.1016\/j.medcli.2021.07.029_bib0230"},{"key":"10.1016\/j.medcli.2021.07.029_bib0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2021.07.029_bib0240","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.medcli.2021.07.029_bib0245","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1210\/clinem\/dgz203","article-title":"Prevalence and mortality of individuals with X-linked hypophosphataemia: A United Kingdom real world data analysis","volume":"105","author":"Hawley","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2021.07.029_bib0250","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00005792-198911000-00002","article-title":"X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults","volume":"68","author":"Reid","year":"1989","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.medcli.2021.07.029_bib0255","doi-asserted-by":"crossref","first-page":"e1798","DOI":"10.1210\/clinem\/dgaa064","article-title":"Osteoarthritis Osteophytes, and Enthesophytes Affect Biomechanical Function in Adults With X-linked Hypophosphatemia","volume":"105","author":"Steele","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2021.07.029_bib0260","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jbspin.2019.01.012","article-title":"X-linked hypophosphatemia: Management and treatment prospects","volume":"86","author":"Lambert","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.medcli.2021.07.029_bib0265","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.medcli.2021.07.029_bib0270","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.medcli.2021.07.029_bib0275","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.medcli.2021.07.029_bib0280","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1210\/clinem\/dgz203","article-title":"Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis","volume":"105","author":"Hawley","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2021.07.029_bib0285","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2021.07.029_bib0290","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.medcli.2021.07.029_bib0295","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab Therapy in Children with X-Linked Hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2021.07.029_bib0300","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm","volume":"34","author":"Insogna","year":"2019","journal-title":"International Trial. J Bone Miner Res"},{"key":"10.1016\/j.medcli.2021.07.029_bib0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.medcli.2021.07.029_bib0310","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.medcli.2021.07.029_bib0315","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"unstructured":"The ADAPTE Collaboration. The ADAPTE Process: Resource Toolkit for GUideline Adaptation. Version 2.0; 2019. [consultado 12 Feb 2021]. Disponible en: https:\/\/g-i-n.net\/document-store\/working-groups-documents\/adaptation\/resources\/adapte-resource-toolkit-guideline-adaptation-2-0.pdf","key":"10.1016\/j.medcli.2021.07.029_bib0320"},{"key":"10.1016\/j.medcli.2021.07.029_bib0325","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"advancing guideline development, reporting and evaluation in health care","volume":"63","author":"Brouwers","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.medcli.2021.07.029_bib0330","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.medcli.2021.07.029_bib0335","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2021.07.029_bib0340","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2021.07.029_bib0345","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: Proposal of diagnostic criteria using FGF23 measurement","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.medcli.2021.07.029_bib0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.15568\/am.2020.809.or02","article-title":"Variaci\u00f3n de la fosfaturia en relaci\u00f3n a la ingesta de f\u00f3sforo","volume":"105","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Actual Med"},{"key":"10.1016\/j.medcli.2021.07.029_bib0355","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3476(97)70162-8","article-title":"Urinary phosphate\/creatinine, calcium\/creatinine, and magnesium\/creatinine ratios in a healthy pediatric population","volume":"131","author":"Matos","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.medcli.2021.07.029_bib0360","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00467-018-4180-3","article-title":"Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia","volume":"34","author":"Hernandez-Frias","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.medcli.2021.07.029_bib0365","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1210\/jcem.82.8.4181","article-title":"Cardiovascular abnormalities in patients with X-linked hypophosphatemia","volume":"82","author":"Nehgme","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.medcli.2021.07.029_bib0370","first-page":"153892","article-title":"Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH)","author":"Rothenbuhler","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.medcli.2021.07.029_bib0375","article-title":"Agreement Between Chronological Age and Bone Age Based on the Greulich and Pyle Atlas for Age Estimation: A Systematic Review","author":"Dahlberg","year":"2017","journal-title":"Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Mar. Report from the Norwegian Institute of Public Health No. 2017-21."},{"key":"10.1016\/j.medcli.2021.07.029_bib0380","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00150314","article-title":"An official European Respiratory Society\/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.medcli.2021.07.029_bib0385","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00431-014-2454-8","article-title":"Sex-, age-, and height-specific reference curves for the 6-min walk test in healthy children and adolescents","volume":"174","author":"Saraff","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.medcli.2021.07.029_bib0390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-020-00664-9","article-title":"The Causes of Hypo- and Hyperphosphatemia in Humans","volume":"108","author":"Koumakis","year":"2021","journal-title":"Calcif Tissue Int"},{"unstructured":"EuroQol. 2020 [consultado 12 Feb 2021]. Disponible en: https:\/\/euroqol.org\/","key":"10.1016\/j.medcli.2021.07.029_bib0395"},{"key":"10.1016\/j.medcli.2021.07.029_bib0400","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0031-3955(05)70485-5","article-title":"New perspectives on the biology and treatment of X-linked hypophosphatemic rickets","volume":"44","author":"Carpenter","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.medcli.2021.07.029_bib0405","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.medcli.2021.07.029_bib0410","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1542\/peds.108.1.e6","article-title":"Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia","volume":"108","author":"Seikaly","year":"2001","journal-title":"Pediatrics"},{"unstructured":"European Medicines Agency. 2020. Crysvita [consultado 19 Feb 2021]. Disponible en: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/summaries-opinion\/crysvita","key":"10.1016\/j.medcli.2021.07.029_bib0415"},{"unstructured":"European Medicines Agency. Crysvita. Ficha t\u00e9cnica o resumen de las caracter\u00edsticas del producto; 2020. [consultado 19 Feb 2021]. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/crysvita-epar-product-information_es.pdf","key":"10.1016\/j.medcli.2021.07.029_bib0420"},{"key":"10.1016\/j.medcli.2021.07.029_bib0425","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.3544","article-title":"Burosumab: At Long Last, an Effective Treatment for FGF23-Associated Hypophosphatemia","volume":"33","author":"Collins","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.medcli.2021.07.029_bib0430","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2021.07.029_bib0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fped.2020.00048","article-title":"Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia","volume":"8","author":"Mart\u00edn Ramos","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.medcli.2021.07.029_bib0440","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00198-017-3949-8","article-title":"Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets","volume":"28","author":"Colares Neto","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.medcli.2021.07.029_bib0445","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease","volume":"10","author":"Scialla","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2021.07.029_bib0450","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1007\/s12325-019-01184-1","article-title":"Hypophosphataemic Rickets: Diagnosis Algorithm-How Not to Make a Mistake","volume":"37","author":"Gonz\u00e1lez-Lamu\u00f1o","year":"2020","journal-title":"Adv Ther"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321005388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775321005388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:54:30Z","timestamp":1758419670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775321005388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0025775321005388"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2021.07.029","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones de pr\u00e1ctica cl\u00ednica para el diagn\u00f3stico y el tratamiento de la hipofosfatemia ligada al cromosoma X: un consenso basado en el m\u00e9todo ADAPTE","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2021.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}